C Hakansson
Overview
Explore the profile of C Hakansson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
88
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jochems C, Lagerquist M, Hakansson C, Ohlsson C, Carlsten H
Clin Exp Immunol
. 2008 Apr;
152(3):593-7.
PMID: 18435803
Both oestrogen deficiency and the inflammatory disease contribute to the generalized bone loss seen in postmenopausal rheumatoid arthritis (RA). Oestradiol and the selective oestrogen receptor modulator raloxifene have been shown...
2.
Windahl S, Lagerquist M, Andersson N, Jochems C, Kallkopf A, Hakansson C, et al.
Endocrinology
. 2007 Sep;
148(12):5688-95.
PMID: 17761761
Estrogen has bone protective effects, but the exact mechanism behind these effects remains unclear. The aim of the present study was to identify the primary target cells in bone for...
3.
Bergbrant I, Hakansson C, Lowhagen G, Voog E
Lakartidningen
. 1995 Nov;
92(45):4172-4.
PMID: 7475537
No abstract available.
4.
Hallonsten A, Wendt L, Mejare I, Birkhed D, Hakansson C, Lindvall A, et al.
Int J Paediatr Dent
. 1995 Sep;
5(3):149-55.
PMID: 9601235
Three thousand children aged 18 months were screened for dental caries and ongoing breast-feeding at 46 child welfare centres in different parts of Sweden. Of these, 200 children were selected...
5.
Thorsen S, Pedersen C, Sandstrom E, PETERSEN C, Norkrans G, Gerstoft J, et al.
Ugeskr Laeger
. 1994 May;
156(22):3314-8.
PMID: 7520643
The safety and efficacy of isoprinosine in HIV-infected individuals were assessed in a multicentre, randomized, double-blind, 24-week study phase, followed by an optional 24-week open treatment phase. The results of...
6.
Thorsen S, Pedersen C, Sandstrom E, PETERSEN C, Norkrans G, Gerstoft J, et al.
J Intern Med
. 1992 Jun;
231(6):607-15.
PMID: 1377741
The safety and clinical impact of isoprinosine in HIV-infected individuals were assessed in a multicentre, randomized, double-blind, 24-week study phase, followed by an optional 24-week open treatment phase. The results...
7.
Pedersen C, Sandstrom E, PETERSEN C, Norkrans G, Gerstoft J, Karlsson A, et al.
N Engl J Med
. 1990 Jun;
322(25):1757-63.
PMID: 1693173
We performed a randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of inosine pranobex (Isoprinosine) [corrected] in the treatment of patients with human immunodeficiency virus (HIV) infection but...
8.
THOREN K, Hakansson C, Bergstrom T, Johanisson G, Norkrans G
Sex Transm Dis
. 1990 Apr;
17(2):72-4.
PMID: 2193407
In a randomized trial, the authors treated 42 asymptomatic homosexual men who had Entamoeba histolytica in fecal specimens with either metronidazole or tinidazole (study 1). They treated both groups initially...
9.
Ramstedt K, Hallhagen G, Lundin B, Hakansson C, Johannisson G, Lowhagen G, et al.
Sex Transm Dis
. 1990 Jan;
17(1):37-41.
PMID: 2305335
Contact tracing--or partner notification--is a generally accepted method for the control of sexually transmitted diseases (STDs), but its use as an epidemiological tool against the spread of acquired immunodeficiency syndrome...
10.
Giesecke J, Hakansson C, Karlsson A, Lidman K
Scand J Infect Dis
. 1990 Jan;
22(4):407-11.
PMID: 2218403
The time from infection with HIV to symptoms and AIDS is an important parameter in describing the natural course of HIV infection. We here describe disease progression in a group...